Phase 1 - enzalutamide and fulvestrant advanced BC

Options

http://www.sciencedaily.com/releases/2015/12/15120...

Researchers report promising results of a phase 1 clinical trial of combination enzalutamide and fulvestrant against advanced breast cancer.


Phase 1 results point to larger trial of enzalutamide and fulvestrant in breast cancer

Categories